aiqbench takeAI Safety

This breach highlights a critical vulnerability in pharmaceutical R&D where attackers targeted not just patient records but also high-value proprietary AI models like NovoPert. The exfiltration of trained model checkpoints and source code underscores that advanced healthcare organizations must now treat their internal machine learning infrastructure as prime targets for intellectual property theft. For the industry, this incident signals an urgent need to harden access controls around generative biology tools and multimodal datasets used in drug discovery pipelines.

Sources coveringCybersecurity News, Viakoo, Quantum Zeitgeist, AWS

What this isA model's reading of the article and related coverage, written for aiqbench. Not the publisher's words.

Novo Nordisk Confirms Cyber Attack — Hackers Accessed Patient Medical Data and Internal AI Assets

Cybersecurity NewsJune 16, 20263 min read

Danish pharmaceutical giant Novo Nordisk has confirmed a cyberattack in which threat actors gained unauthorized access to internal IT systems, exfiltrating pseudonymized patient data from clinical trials and, according to the alleged attackers, a trove of proprietary AI model assets. Novo Nordisk disclosed the incident on June 11, 2026, stating that attackers copied “certain non-public […] The post Novo Nordisk Confirms Cyber Attack — Hackers Accessed Patient Medical Data and Internal AI Assets appeared first on Cyber Security News.

Excerpt shown under the publisher's RSS terms · 49 words · full text and figures are on the publisher's site

Read at Cybersecurity News ↗Ask about this article